What are the indications, dosing recommendations, and contraindications for hydroxyzine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydroxyzine: Clinical Overview

Hydroxyzine is a first-generation sedating H1-antihistamine indicated primarily for urticaria, allergic rhinitis, pruritus, and anxiety, but should generally be avoided as first-line therapy due to significant sedation, performance impairment, and cardiac risks including QT prolongation. 1

Primary Indications

Approved Uses

  • Urticaria (hives): Can be added at night (10-50 mg) to a non-sedating antihistamine taken during the day, though this provides minimal additional benefit on urticaria itself if H1 receptors are already saturated—the main advantage is improved sleep 2
  • Allergic rhinitis: Effective for symptom suppression but second-generation antihistamines are strongly preferred 3
  • Pruritus: Effective antipruritic agent, particularly in atopic dermatitis 4
  • Anxiety disorders: Demonstrated efficacy in generalized anxiety disorder at 50 mg/day 5
  • Insomnia: May be considered for short-term use when other therapies have failed 6

Dosing Recommendations

Adults

  • Urticaria/pruritus: 10-50 mg at bedtime 2
  • Allergic rhinitis: Titrate slowly up to 150 mg/day to minimize sedation 7
  • Anxiety: 50 mg/day 5

Pediatrics

  • Atopic dermatitis/pruritus: 0.7 mg/kg three times daily is as effective as 1.4 mg/kg three times daily but causes significantly less sedation 4
  • Peak serum concentration occurs at 2 hours with elimination half-life of 7.1 hours in children 4

Dose Adjustments

  • Renal impairment: Halve the dose in moderate impairment (creatinine clearance 10-20 mL/min); avoid in severe impairment (creatinine clearance <10 mL/min) 2
  • Hepatic impairment: Avoid in severe liver disease due to inappropriate sedating effects 2
  • Elderly: Start at low doses due to increased sensitivity to sedation, anticholinergic effects, and risk of falls 1

Critical Contraindications

Absolute Contraindications 1

  • Prolonged QT interval or congenital long QT syndrome
  • Early pregnancy (specifically contraindicated in first trimester—the only antihistamine with this designation)
  • Known hypersensitivity to hydroxyzine, cetirizine, or levocetirizine
  • Severe hepatic impairment

Relative Contraindications/Cautions

  • Cardiac risk factors: Recent myocardial infarction, uncompensated heart failure, bradyarrhythmias, electrolyte imbalances 1
  • Concomitant QT-prolonging drugs: Class IA/III antiarrhythmics, certain antipsychotics (ziprasidone, quetiapine), antidepressants (citalopram, fluoxetine), macrolide antibiotics, fluoroquinolones 1, 8
  • Elderly patients: Higher risk of confusion, oversedation, falls, and anticholinergic complications 1

Important Safety Considerations

Sedation and Performance Impairment

Hydroxyzine causes significant sedation and performance impairment that persists beyond subjective awareness of drowsiness 3. Key concerns include:

  • Drivers taking first-generation antihistamines are 1.5 times more likely to be responsible for fatal automobile accidents 3
  • Impaired driving performance worsens with cellular phone use 3
  • Impaired learning and school performance in children 3
  • Increased occupational accidents 3
  • Effects persist into the next day even when dosed only at bedtime due to prolonged half-life 3

Cardiac Toxicity

  • QT prolongation and Torsade de Pointes reported in post-marketing surveillance, particularly in patients with pre-existing risk factors 1
  • Abnormal ventricular repolarization may occur, especially with substantial doses or in susceptible individuals 8
  • Risk amplified by concurrent use of other QT-prolonging medications 1

Drug Interactions

  • CNS depressants: Reduce dosage of narcotics, non-narcotic analgesics, and barbiturates when used with hydroxyzine due to potentiating effects 1
  • Alcohol: Effects significantly enhanced 1

Dermatologic Reactions

  • Acute Generalized Exanthematous Pustulosis (AGEP): Rare but serious skin reaction characterized by fever and sterile pustules 1
  • Discontinue immediately if skin rash develops or pre-existing skin conditions worsen 1

Clinical Positioning

When to Use Hydroxyzine

Hydroxyzine should be reserved for specific scenarios:

  1. Nighttime adjunct to non-sedating antihistamines in urticaria when sleep is disrupted 2
  2. Short-term use in generalized pruritus of unknown origin when sedation is acceptable 9
  3. Palliative settings where sedation may be beneficial 9
  4. Treatment failures with second-generation antihistamines in carefully selected patients 6

When to Avoid Hydroxyzine

Second-generation antihistamines are strongly preferred over hydroxyzine for allergic rhinitis and urticaria 3. Avoid hydroxyzine in:

  • Patients who drive or operate machinery
  • Elderly patients (use only in palliative/short-term settings) 9
  • Patients with cardiac disease or risk factors for arrhythmias
  • Pregnant women, especially first trimester 2
  • Patients taking other CNS depressants or QT-prolonging drugs

Common Pitfalls

  1. Assuming hydroxyzine has the same antimuscarinic profile as diphenhydramine: Hydroxyzine produces fewer antimuscarinic findings than diphenhydramine, with more prominent CNS depression 10

  2. Using AM/PM split dosing (second-generation in morning, hydroxyzine at night): This strategy does NOT avoid daytime drowsiness and performance impairment due to prolonged half-life and persistent end-organ effects 3

  3. Overlooking cardiac screening: Always assess for QT prolongation risk factors before prescribing 1

  4. Prescribing in pregnancy: Hydroxyzine is the only antihistamine specifically contraindicated in early pregnancy; choose chlorphenamine if antihistamine therapy is essential 2

  5. Inadequate dose adjustment in renal/hepatic impairment: Failure to halve doses or avoid use entirely can lead to excessive sedation and adverse effects 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.